MARCH 01, 2004

Doak Dermatologics (Fairfield, NJ), a subsidiary of Bradley Pharmaceuticals Inc, has announced the introduction of a new prescription-only topical acne treatment, Zoderm. Zoderm contains benzoyl peroxide in a special moisturizing base of 10% urea. The product is available in gel, cream, and cleanser form in 4.5% (for mild acne) and 8.5% (for moderate-to-severe acne) strengths of benzoyl peroxide. The Zoderm family of treatments represents an innovative departure from traditional benzoyl peroxide acne therapies, resulting in excellent tolerability, even in patients with sensitive skin. For more information, visit www.doakderm.com, or call 800-405- DOAK (800-405-3625).